Phone-Based Postpartum Continuing Care: Smoking Cessation Beginning in Pregnancy

基于电话的产后持续护理:从怀孕开始戒烟

基本信息

项目摘要

DESCRIPTION (provided by applicant): The large majority of women who quit smoking during pregnancy relapse in the first six months postpartum, highlighting a need for effective postpartum continuing care that supports women through the challenging postpartum period when stress is high and motivation to stay quit may decline. Existing relapse prevention interventions (typically delivered during pregnancy) have been found to be of little benefit during the postpartum period, suggesting the need for a more formal continuing care approach. Phone-based protocols for smoking cessation have been widely disseminated and effective because they address the need for flexible access, but are passive and not typically utilized by women in the postpartum period. The proposed pilot study will develop and test a Phone-based Postpartum Continuing Care (PPCC) model that draws from existing evidence-based protocols--the 5 A's and Recovery Management Checkups (RMC)-- shown to be effective with other populations. The experimental PPCC will reinforce the importance of abstinence, relapse prevention, and reduced smoking through proactive re-intervention (i.e., RMC) with the 5 A's at times when postpartum women are more likely to relapse, and provide education and monitoring of the infant's direct and indirect exposure to nicotine through breastfeeding and secondhand smoke. We will evaluate PPCC's effectiveness relative to a passive referral to a 24/7 hotline, which is current standard care.., Approximately one hundred thirty women in their first or second trimester of pregnancy who were nicotine-dependent in the past year, currently smoke, or quit within the past 90 days will be recruited at their first prenatal appointment at the Maryland Women's Center (MWC) in Baltimore, Maryland. All women will receive the clinic's standard of care for smoking cessation--the 5 A's --during pregnancy from their physician. Half will be randomly assigned to an experimental group getting PPCC for 6 months postpartum and half to a control group receiving only a referral to a passive 24/7 state quit line postpartum. It s expected that in the 6 months following childbirth women in the experimental PPCC (relative to those in the control group) will: a) smoke fewer cigarettes, b) smoke fewer days, c) go longer before postpartum relapse, d) have less time between relapse and talking to a health professional about smoking, e) have less time between relapse and resumption of abstinence , f) smoke fewer times while breastfeeding, g) smoke fewer times while in the same room as the infant, and h) reduce their infant's cotinine levels. The aims of this pilot project are to develo PPCC from existing evidence-based approaches, demonstrate the feasibility of implementing the PPCC intervention with at least 80% compliance and at least 80% follow-up at each wave, and evaluate the effect size associated with receiving standard care vs. standard care + PPCC in order to understand the promise of and appropriate power required for a larger clinical trial.
描述(由申请人提供):绝大多数在产后头六个月妊娠复发期间戒烟的妇女,强调需要有效的产后继续护理,这些护理在充满挑战的产后压力很大,保持戒烟的动力可能会下降。现有的预防复发干预措施(通常在怀孕期间提供)在 产后时期,表明需要采用更正式的持续护理方法。基于电话的戒烟协议已被广泛传播和有效,因为它们满足了灵活访问的需求,但是被动的,并且通常在产后时期不被女性使用。 拟议的试点研究将开发和测试基于电话的产后持续护理(PPCC)模型,该模型从现有的基于证据的协议(5 A和恢复管理检查(RMC))中汲取了帮助,该协议与其他人群有效。实验性的PPCC将通过主动重新干预(即RMC)的戒酒,预防复发和减少吸烟的重要性,有时5 A的产后妇女更有可能复发,并通过母乳喂养和秒向吸烟和尼古丁进行教育和监测,并提供教育和监测。我们将评估PPCC相对于24/7热线的被动转介的有效性,这是当前的标准护理..,在过去一年中依赖于尼古丁的第一或第二三个月,大约一百三十名妇女在过去的90天内被吸烟,或者在过去的90天内被戒烟。 马里兰州巴尔的摩的马里兰州妇女中心(MWC)。所有妇女都将获得诊所的戒烟标准(5 A)的医生怀孕。一半将被随机分配给一个实验组,在产后6个月内将PPCC归为一半,而将仅接收到被动24/7国家退出线产后的对照组。 It s expected that in the 6 months following childbirth women in the experimental PPCC (relative to those in the control group) will: a) smoke fewer cigarettes, b) smoke fewer days, c) go longer before postpartum relapse, d) have less time between relapse and talking to a health professional about smoking, e) have less time between relapse and resumption of abstinence , f) smoke fewer times while breastfeeding, g) smoke fewer times while in the same作为婴儿的空间,h)降低婴儿的可替宁水平。 该试点项目的目的是从现有的基于证据的方法中脱离PPCC,证明了以至少80%的合规性实施PPCC干预的可行性,并且在每个波浪时至少进行了80%的随访,并评估与接受标准护理相关的效果大小与接受标准护理与标准护理 + PPCC相关的效果,以了解较大的临床临床试验的承诺,并需要适当的电力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Victoria Hope Coleman-Cowger其他文献

Victoria Hope Coleman-Cowger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Victoria Hope Coleman-Cowger', 18)}}的其他基金

Sickle Cell Disease Cure Initiative (SCDC)
镰状细胞病治愈计划 (SCDC)
  • 批准号:
    10700477
  • 财政年份:
    2017
  • 资助金额:
    $ 20.12万
  • 项目类别:
Sickle Cell Disease Cure Initiative (SCDC)
镰状细胞病治愈计划 (SCDC)
  • 批准号:
    9564481
  • 财政年份:
    2017
  • 资助金额:
    $ 20.12万
  • 项目类别:
Sickle Cell Disease Cure Initiative (SCDC)
镰状细胞病治愈计划 (SCDC)
  • 批准号:
    10469101
  • 财政年份:
    2017
  • 资助金额:
    $ 20.12万
  • 项目类别:
Sickle Cell Disease Cure Initiative (SCDC)
镰状细胞病治愈计划 (SCDC)
  • 批准号:
    10931959
  • 财政年份:
    2017
  • 资助金额:
    $ 20.12万
  • 项目类别:
Comparison of Substance Use Screeners in Assessing Prescription Drug Abuse and Other Illicit Drug Use among Pregnant Women
药物使用筛查仪在评估孕妇处方药滥用和其他非法药物使用方面的比较
  • 批准号:
    9193487
  • 财政年份:
    2016
  • 资助金额:
    $ 20.12万
  • 项目类别:
Comparison of Substance Use Screeners in Assessing Prescription Drug Abuse and Other Illicit Drug Use among Pregnant Women
药物使用筛查仪在评估孕妇处方药滥用和其他非法药物使用方面的比较
  • 批准号:
    9350269
  • 财政年份:
    2016
  • 资助金额:
    $ 20.12万
  • 项目类别:
Comparison of Substance Use Screeners in Assessing Prescription Drug Abuse and Other Illicit Drug Use among Pregnant Women
药物使用筛查仪在评估孕妇处方药滥用和其他非法药物使用方面的比较
  • 批准号:
    9762358
  • 财政年份:
    2016
  • 资助金额:
    $ 20.12万
  • 项目类别:
Phone-Based Postpartum Continuing Care: Smoking Cessation Beginning in Pregnancy
基于电话的产后持续护理:从怀孕开始戒烟
  • 批准号:
    8386735
  • 财政年份:
    2012
  • 资助金额:
    $ 20.12万
  • 项目类别:
Phone-Based Postpartum Continuing Care: Smoking Cessation Beginning in Pregnancy
基于电话的产后持续护理:从怀孕开始戒烟
  • 批准号:
    8884766
  • 财政年份:
    2012
  • 资助金额:
    $ 20.12万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of a Novel Peer-Narrated Virtual Patient Decision Aid for Entry into Alcohol Treatment for ICU Survivors with Alcohol Misuse
开发新型同伴叙述虚拟患者决策辅助工具,帮助 ICU 酗酒幸存者接受酒精治疗
  • 批准号:
    10679242
  • 财政年份:
    2023
  • 资助金额:
    $ 20.12万
  • 项目类别:
Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital
针对儿科医院青少年和年轻人制定和实施烟草和电子尼古丁传送系统使用干预措施
  • 批准号:
    10425881
  • 财政年份:
    2022
  • 资助金额:
    $ 20.12万
  • 项目类别:
NorthStar Node of the Clinical Trials Network
临床试验网络的 NorthStar 节点
  • 批准号:
    10682035
  • 财政年份:
    2022
  • 资助金额:
    $ 20.12万
  • 项目类别:
Modulation of protracted opioid withdrawal by dorsal raphe dynorphin neurons
中缝背侧强啡肽神经元对长期阿片类药物戒断的调节
  • 批准号:
    10505724
  • 财政年份:
    2022
  • 资助金额:
    $ 20.12万
  • 项目类别:
C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations
C-DIAS RP 2:在专业成瘾治疗组织中实施兴奋剂使用应急管理
  • 批准号:
    10668488
  • 财政年份:
    2022
  • 资助金额:
    $ 20.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了